The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
“Even with all of the advances in diabetes technology, insulin therapy is still overwhelming and complex,” said Mike Mason, who heads Lilly’s connected care and insulins programme. Bundling ...
The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...
In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
Rimidi's system will be targeted at primary care providers, allowing them to use analytics and platforms, such as Lilly's integrated insulin management system, to improve care for specific patient ...
Shares of Eli Lilly and Co. fell more than 7% in midday trading Tuesday after the Indianapolis company announced its fourth ...
Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity ... revenue as the market for drugs that increase insulin levels grew more slowly than expected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback